| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 15.03.2001 (8602
dage). |
Ingen historik.
| Branche | | Fremstilling af farmaceutiske præparater (212000). |
| Sidst opdateret den 23.12.2007 og
angivet som gældende fra 01.01.2008 (6119
dage). |
| Historik | Start | Stop |
|---|
| Fremstilling af farmaceutiske præparater (212000) | 01.01.2008 | |
| Medicinalvarefabrikker (244200) | 15.03.2001 | 31.12.2007 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 15.03.2001 (8602
dage). |
Ingen historik.
| Revisor | | KPMG P/S |
| Sidst opdateret den 09.06.2017 og
angivet som gældende fra 31.05.2017 (2681
dage). |
| Historik | Start | Stop |
|---|
| info@cmcbiotech.com | 15.02.2004 | 09.12.2004 |
| Virksomheden har ikke ændret Kontakt i sin
levetid. |
Ingen nuværende registrering.
| Telefonnummer | | 70209470. |
| Sidst opdateret den 17.02.2004 og
angivet som gældende fra 15.02.2004 (7535
dage). |
Ingen historik.
| Navne | | AGC Biologics A/S. |
| Sidst opdateret den 30.11.2018 og
angivet som gældende fra 30.11.2018 (2133
dage). |
| Historik | Start | Stop |
|---|
| AGC Biologics A/S | 30.11.2018 | |
| CMC BIOLOGICS A/S | 29.02.2008 | 29.11.2018 |
| CMC BIOPHARMACEUTICALS A/S | 18.10.2002 | 28.02.2008 |
| CMC BIOTECH A/S | 15.03.2001 | 17.10.2002 |
| Binavne | | CMC Biologics A/S. |
| Sidst opdateret den 30.11.2018 og
angivet som gældende fra 30.11.2018 (2133
dage). |
| Historik | Start | Stop |
|---|
| CMC Biologics A/S | 30.11.2018 | |
| CMC BIO A/S | 15.03.2001 | |
| CMC BIOPHARMACEUTICALS A/S | 15.03.2001 | |
| CMC BIOTECH A/S | 15.03.2001 | |
| CMO BIOTECH A/S | 15.03.2001 | |
| CRO BIOTECH A/S | 15.03.2001 | |
| DOWNSTREAM TECHNOLOGY A/S | 15.03.2001 | |
| CMC BIOLOGICS A/S | 15.03.2001 | 29.02.2008 |
| Tegningsregel | | Selskabet tegnes af bestyrelsens formand i forening med en direktør, af bestyrelsens formand i forening med 2 bestyrelsesmedlemmer, 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse. |
| Sidst opdateret den 05.04.2017 og
angivet som gældende fra 05.04.2017 (2737
dage). |
| Fortolkning
(4 tegningsmuligheder)
| | formanden + 1 direktør |
| formanden + 2 bestyrelsesmedlemmer |
| 2 bestyrelsesmedlemmer + |
| bestyrelsen |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af bestyrelsens formand i forening med en direktør, af bestyrelsens formand i forening med 2 bestyrelsesmedlemmer, 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse | 05.04.2017 | |
| Selskabet tegnes af bestyrelsens formand i forening med en direktør, af bestyrelsens formand i forening med 2 bestyrelsesmedlemmer, 2 bestyrelsesmedlemmer i forening med en direktør eller af den samlede bestyrelse | 01.02.2017 | 04.04.2017 |
| Selskabet tegnes af bestyrelsens formand i forening med en direktør, af bestyrelsens formand i forening med 2 bestyrelsesmedlemmer og af 2 bestyrelsesmedlemmer i forening med en direktør og af den samlede bestyrelse | 12.02.2014 | 31.01.2017 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMGStatsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State Authorised Public Accountan
Virksomhedens regnskabsklasse:Reporting class C, large enterprise
Grundlag for konklusion (revision):Basis for OpinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionWe have audited the financial statements of AGC Biologics A/S for the financial year 1 January – 31 December 2023 comprising income statement, balance sheet, statement of changes in equity, cash flow statement and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2023 and of the results of the Company's operations and cash flows for the financial year 1 January – 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s ReviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration